E-LIB Suche - Ergebnisse für: Moreno Garcia, V.

1

43P Updated efficacy and circulating tumour (ct)DNA analysi..:

Drilon, A. ; Lin, J.J. ; Tan, D.S.W....
ESMO Open. 9 (2024) - p. 102622 , 2024

Link: https://doi.org/10.1016/..

2

200MO Anti–IL-8 BMS-986253 + nivolumab (NIVO) ± ipilimumab ..:

Simonelli, M. ; Calvo, E. ; Davar, D....
Immuno-Oncology and Technology. 16 (2022) - p. 100311 , 2022

Link: https://doi.org/10.1016/..

3

175P Safety and preliminary efficacy of GEN1042 (DuoBody-CD..:

Melero, I. ; Grande Pulido, E. ; De Miguel Luken, M.J....
Immuno-Oncology and Technology. 16 (2022) - p. 100287 , 2022

Link: https://doi.org/10.1016/..

4

MCLA-129, a human anti-EGFR and anti-c-MET bispecific antib..:

Ou, S.H. ; Moreno Garcia, V. ; Gil Bazo, I....
European Journal of Cancer. 174 (2022) - p. S122 , 2022

Link: https://doi.org/10.1016/..

5

196TiP A phase I study of REGN6569, a GITR monoclonal antib..:

Lakhani, N. ; Hamid, O. ; Braña, I....
Immuno-Oncology and Technology. 16 (2022) - p. 100308 , 2022

Link: https://doi.org/10.1016/..

6

173P First-in-human study to evaluate the safety and clinic..:

De Velasco Oria, G.A. ; Garralda, E. ; Moreno Garcia, V....
Immuno-Oncology and Technology. 16 (2022) - p. 100285 , 2022

Link: https://doi.org/10.1016/..

7

Phase I Study of Novel Radioenhancer NBTXR3 Activated by Ra..:

Le Tourneau, C. ; Calugaru, V. ; Takacsi-Nagy, Z....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e392 , 2021

Link: https://doi.org/10.1016/..

8

Hafnium Oxide Nanoparticles Activated By Radiation Therapy ..:

Le Tourneau, C. ; Thariat, J.O. ; Chajon Rodriguez, E....
International Journal of Radiation Oncology*Biology*Physics. 102 (2018) 3 - p. e185 , 2018

Link: https://doi.org/10.1016/..

9

Prognostic value of carcinoembryonic antigen level in recta..:

Moreno García, V. ; Cejas, P. ; Blanco Codesido, M....
International Journal of Colorectal Disease. 24 (2009) 7 - p. 741-748 , 2009

Link: https://doi.org/10.1007/..

10

61MO Phase Ia/Ib study of the MDM2-p53 antagonist brigimadl..:

Reichardt, P. ; Schöffski, P. ; Lorusso, P....
ESMO Open. 9 (2024) - p. 102451 , 2024

Link: https://doi.org/10.1016/..

11

First-line ADP-A2M4CD8 T-cell Receptor T-cell Therapy plus ..:

Ho, A. ; Garcia-Consuegra, A. ; Saro, J....
International Journal of Radiation Oncology*Biology*Physics. 118 (2024) 5 - p. e84-e85 , 2024

Link: https://doi.org/10.1016/..

12

176P Liver pharmacodynamics in an open-label phase Ib/IIa s..:

Chon, H.J. ; Heo, J. ; Monzon, M.E. Reig...
Annals of Oncology. 35 (2024) - p. S80 , 2024

Link: https://doi.org/10.1016/..

13

160TiP Safety and antitumor activity of GEN1042 in combinat..:

Melero, I. ; Grande, E. ; Johnson, M.L....
Immuno-Oncology and Technology. 20 (2023) - p. 100671 , 2023

Link: https://doi.org/10.1016/..

14

15MO Efficacy and ctDNA analysis in an updated cohort of pa..:

Hoejgaard, M. ; Drilon, A. ; Lin, J.J....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S48-S49 , 2023

Link: https://doi.org/10.1016/..

15

OC-043 HNSCC in elderly frail patients treated by hafnium o..:

Hoffmann, C. ; Calugaru, V. ; Garcia, V. Moreno...
Radiotherapy and Oncology. 132 (2019) - p. 22-23 , 2019

Link: https://doi.org/10.1016/..